Effectiveness of the Medical Chatbot PROSCA to Inform Patients About Prostate Cancer: Results of a Randomized Controlled Trial
This study evaluated an artificial intelligence-powered chatbot-PROSCA, a digital tool designed to support men facing prostate cancer diagnosis by providing validated information from diagnosis to treatment. Results showed that patients who used the chatbot as an additional tool felt better informed than those who received standard information from urologists. The majority of users appreciated the ease of use of the chatbot and expressed a desire to use it again; this suggests that PROSCA could be a valuable resource to improve patient understanding in prostate cancer diagnosis.
Authors
- Heinz‐Peter Schlemmer (ORCID: https://orcid.org/0000-0002-9291-0954)
- Magdalena Görtz (ORCID: https://orcid.org/0000-0001-6195-1609)
- T Schmid (ORCID: https://orcid.org/0000-0002-5184-6757)
- Axel Gerlach
- David Bonekamp (ORCID: https://orcid.org/0000-0002-4811-0087)
- Philipp Woessner
- Markus Hohenfellner (ORCID: https://orcid.org/0000-0003-3798-2039)
- Michael Byczkowski (ORCID: https://orcid.org/0000-0001-7004-1586)
- Kilian Baumgärtner
- Marc Muschko
Institutions
- German Cancer Research Center (DE)
- Heidelberg University (DE)
- University Hospital Heidelberg (DE)
- Systems, Applications & Products in Data Processing (Germany) (DE)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2024-09-17
- DOI
- https://doi.org/10.1016/j.euros.2024.08.022
- Citations
- 20
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 2.41